Previous 10 |
home / stock / chexf / chexf news
OTTAWA, March 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to ...
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, March 12, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or...
OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, announces an up...
OTTAWA, Feb. 23, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to a...
OTTAWA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, announces that ...
OTTAWA, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the use of antibiotics added to livestock feeds...
OTTAWA, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the use of antibiotics added to livestock feeds as growth promoters, announces ...
News, Short Squeeze, Breakout and More Instantly...
Phoenix, Arizona--(Newsfile Corp. - October 2, 2019) - The Stock Day Podcast welcomed Avivagen Inc. (CHEXF) ("the Company"), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune f...
PHOENIX, May 13, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Avivagen Inc. (CHEXF) , a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, pro...
OTTAWA, March 06, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) reported today its unaudited financial results for Q1 2019. For the three-month period ended January 31, 2019, the Corporation reported revenues of $322,125 &...